IOM. 2001. Veterans and Agent Orange: Update 2000. Washington, DC: National Academy Press.

IOM. 2003. Veterans and Agent Orange: Update 2002. Washington, DC: The National Academies Press.

IOM. 2005. Veterans and Agent Orange: Update 2004. Washington, DC: The National Academies Press.

IOM. 2007. Veterans and Agent Orange: Update 2006. Washington, DC: The National Academies Press.

Jirasek L, Kalensky J, Kubec K, Pazderova J, Lukas E. 1974. Chronic poisoning by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Ceskoslovenska Dermatologie 49:145–157.

Jung D, Konietzko J, Reill-Konietzko G, Muttray A, Zimmermann-Holz HJ, Doss M, Beck H, Edler L, Kopp-Schneider A. 1994. Porphyrin studies in TCDD-exposed workers. Archives of Toxicology 68:595–598.

May G. 1973. Chloracne from the accidental production of tetrachlorodibenzodioxin. British Journal of Industrial Medicine 30:276–283.

May G. 1982. Tetrachlorodibenzodioxin: A survey of subjects ten years after exposure. British Journal of Industrial Medicine 39(2):128–135.

Mocarelli P, Needham LL, Marocchi A, Patterson DG Jr, Brambilla P, Gerthoux PM, Meazza L, Carreri V. 1991. Serum concentrations of 2,3,7,8-tetrachlorodibenzo-p-dioxin and test results from selected residents of Seveso, Italy. Journal of Toxicology and Environmental Health 32:357–366.

Neuberger M, Kundi M, Jäger R. 1998. Chloracne and morbidity after dioxin exposure (preliminary results). Toxicology Letters 96-97:347–350.

Oliver RM. 1975. Toxic effects of 2,3,7,8 tetrachlorodibenzo 1,4-dioxin in laboratory workers. British Journal of Industrial Medicine 32:49–53.

Panteleyev AA, Bickers DR. 2006. Dioxin-induced chloracne—Reconstructing the cellular and molecular mechanisms of a classic environmental disease. Experimental Dermatology 15(9):705–730.

Pazderova-Vejlupkova J, Lukáš E, Nemcova M, Pickova J, Jirasek L. 1981. The development and prognosis of chronic intoxication by tetrachlorodibenzo-p-dioxin in men. Archives of Environmental Health 36:5–11.

Poland AP, Smith D, Metter G, Possick P. 1971. A health survey of workers in a 2,4-D and 2,4,5-T plant with special attention to chloracne, porphyria cutanea tarda, and psychologic parameters. Archives of Environmental Health 22:316–327.

Robinson SW, Clothier B, Akhtar RA, Yang AL, Latour I, Van Ijperen C, Festing MF, Smith AG. 2002. Non-ahr gene susceptibility Loci for porphyria and liver injury induced by the interaction of ‘dioxin’ with iron overload in mice. Molecular Pharmacology 61(3):674–681.

Rosso SB, Caceres AO, Evangelista de Duffard AM, Duffard RO, Quiroga S. 2000a. 2,4-dichlorophenoxyacetic acid disrupts the cytoskeleton and disorganizes the golgi apparatus of cultured neurons. Toxicologic Sciences 56:133–140.

Rosso SB, Garcia GB, Madariaga MJ, De Duffard AME, Duffard RO. 2000b. 2,4-dichlorophenoxyacetic acid in developing rats alters behaviour, myelination and regions brain gangliosides pattern. NeuroToxicology 21(1-2):155–164.

Singer R, Moses M, Valciukas J, Lilis R, Selikoff IJ. 1982. Nerve conduction velocity studies of workers employed in the manufacture of phenoxy herbicides. Environmental Research 29:297–311.

Smith AG, Chernova T. 2009. Chapter 6 disruption of heme synthesis by polyhalogenated aromatics. Advances in Molecular Toxicology 3(C):161–210.

Smith AG, Clothier B, Carthew P, Childs NL, Sinclair PR, Nebert DW, Dalton TP. 2001. Protection of the Cyp1a2 (-/-) null mouse against uroporphyria and hepatic injury following exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology and Applied Pharmacology 173(2):89–98.

Smith AG, Elder GH. 2010. Complex gene-chemical interactions: Hepatic uroporphyria as a paradigm. Chemical Research in Toxicology 23(4):712–723.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement